Latest Posts

Cytotoxic chemotherapy will not be recommended in which of the following performance status of a patient with NSCLC

If a patient of advanced NSCLC, no targetable driver mutation is found and PD-L1 expression is ≥ 50%, which of the following will be the best treatment approach

Which of the following is not true regarding the immune checkpoint inhibitor durvalumab?

For a patient of NSCLC having N2 (stage III) disease, which of the following is an accepted management option :

What is the treatment of choice for Pancoast tumors?

If a patient is suspected of having N0/N1 disease but intraoperatively is found to be having N2 disease, the so called incidental N2 disease; then which of the following will be the best course of treatment :

For patients of T3 N0, 1 M0 NSCLC involving the chest wall, which of the following is the preferred primary therapeutic modality

Last Date: 27/01/2022.Bank of Baroda has released an employment notification for the recruitment of 47 Agriculture Marketing Officer Vacancy. Interested and eligible candidates may apply online here.  Bank of Baroda Recruitment 2022 1. Name of postNo of postsAgriculture Marketing ...

Following complete resection of stage I NSCLC, which of the following adjuvant treatment is indicated?

Surgery is the treatment of choice for stage II NSCLC. As an adjuvant therapy which of the following is recommended in a completely resected stage II NSCLC